Astrazeneca reported 8.87B in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
AstraZeneca AZN:LN 8.87B 244M
Astrazeneca AZN:US 8.87B 244M
Bristol Myers Squibb BMY:US $ 9210M 33M
Canopy Growth Corp WEED:CN C$ -1392000 157.85M
Catalent CTLT:US $ 423M 18M
Corcept Therapeutics CORT:US $ 102.07M 9.63M
Eli Lilly And LLY:US $ 5057.5M 680.4M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Horizon Pharma HZNP:US $ 646.2M 23.99M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Johnson & Johnson JNJ:US $ 16101M 273M
Lannett LCI:US $ 3.08M 2.63M
Merk MRK:US $ 10895M 328M
Novartis NOVN:VX 9.34B 277M
Pacira Pharmaceuticals PCRX:US $ 118.78M 3.13M
Perrigo Ordinary Shares PRGO:US $ 372.1M 34.3M
Pfizer PFE:US $ 19071M 3420M
Phibro Animal Health PAHC:US $ 71.63M 0.95M
Prestige Brands PBH:US $ 160.12M 11.26M
Supernus Pharmaceuticals SUPN:US $ 149.59M 15.02M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M
Valeant Pharmaceuticals VRX:CN $ 1367M 203M
Zoetis ZTS:US $ 1432M 11M